Immunodynamics-Guided Optimization of Individualized Immunochemotherapy in Advanced Driver-Negative NSCLC: A Randomized Trial

Clinical trial NCT07190027 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07190027
Sponsor: First Affiliated Hospital of Wenzhou Medical University
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Non-Small Cell Lung Cancer (NSCLC)

Start date: 2025-11-01
Primary completion: 2025-11-01
Enrollment: 246

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.